Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation

/PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Suzhou ,Jiangsu ,China ,Netherlands ,Jingsong Wang ,Nona Biosciences ,National Medical Products Administration ,Company Hcab ,Biomed The Company ,Harbour Biomed ,Harbour Therapeutic ,Biologics License Application ,